| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;108:2198.)
© 2003 American Heart Association, Inc.
Brief Rapid Communications |
From the Divisions of Cardiovascular Medicine (W.F.F., H.M.O.F., P.J.F., A.C.Y., P.G.Y.) and Cardiothoracic Surgery (L.B.B., D.T.C., R.C.R.), Stanford University Medical Center, Stanford, Calif.
Correspondence to William F. Fearon, MD, Stanford University Medical Center, H3554, 300 Pasteur Dr, Stanford, CA 94305. E-mail wfearon{at}stanford.edu
Received August 12, 2003; revision received September 16, 2003; accepted September 18, 2003.
| Abstract |
|---|
|
|
|---|
Methods and Results In an open-chest pig model, CFRthermo was measured in the left anterior descending (LAD) artery and compared with CFRDoppler and CFRflow, measured with an external flow probe placed around the LAD. In 9 pigs, CFR was measured simultaneously by all 3 means in the normal LAD and after creation of an epicardial LAD stenosis. To determine the added effect of microvascular disease, measurements of flow reserve were also performed after disruption of the coronary microcirculation with embolized microspheres. Intracoronary papaverine (20 mg) was used to induce hyperemia. In a total of 61 paired measurements, CFRthermo correlated strongly with the reference standard CFRflow (r=0.85, P<0.001). CFRDoppler correlated less well with CFRflow (r=0.72, P<0.001). Bland-Altman analysis showed a closer agreement between CFRthermo and CFRflow.
Conclusion CFRthermo correlates better with CFRflow than does CFRDoppler.
Key Words: blood flow coronary disease microcirculation pressure
| Introduction |
|---|
|
|
|---|
In an animal model, De Bruyne et al1 found a significant correlation between CFRthermo and CFR as measured from a Doppler velocity probe placed around the coronary artery (r=0.76, P<0.001). Pijls et al2 then compared CFRthermo to CFRDoppler in humans and again found a significant correlation (r=0.80, P<0.001). However, in the latter study, there were differences between the 2 techniques of more than 20% in one fourth of the cases. Moreover, because of its variability, CFRDoppler may not be an appropriate reference standard.3,4 Which measurement, CFRthermo or CFRDoppler, correlates better with absolute flow-derived CFR (CFRflow) remains unclear. Therefore, the goal of the present study was to further validate CFRthermo by comparing it to both CFRDoppler and CFRflow in an animal model.
| Methods |
|---|
|
|
|---|
Animal Preparation
Yorkshire swine were premedicated with intramuscular ketamine (20 mg/kg), xylazine (2 mg/kg), and buprenorphine (0.005 mg/kg). Anesthesia was maintained with 2% isoflurane, and supplemental oxygen was given via endotracheal intubation. An arterial sheath was surgically placed in the right carotid artery. Angiography of the LAD was performed with a 6F catheter. A lateral thoracotomy was performed by standard surgical technique, the pericardium was opened, and the proximal LAD was circumscribed by a combination of sharp and blunt dissection. An ultrasonic flow probe (Transonic Systems, Inc) was placed around the proximal LAD; a vascular occluder (Harvard Apparatus) was placed distal to the flow probe, ensuring that there were no branch vessels between the two. A bolus of 300 U/kg heparin was administered intravenously.
Epicardial stenoses were created with the vascular occluder so that the distal coronary pressure was 90% of the proximal coronary pressure at rest. The microcirculation was disrupted by selective injection into the LAD of 105 fluorescent microspheres (100 µm diameter; Interactive Medical Technologies).5
Coronary Pressure and Flow Measurements
A coronary pressure wire (Radi Medical Systems) and Doppler velocity wire (Jomed Inc) were advanced into the distal LAD. CFRthermo was measured with the pressure wire and modified software (Radi Medical Systems). The software allows the pressure sensor, which is located 3 cm from the tip of the standard coronary pressure wire, to also act as a distal temperature sensor, whereas the shaft of the wire acts as a proximal temperature sensor; thus, the transit time of an injectant can be calculated. Approximately 3 mL of room-temperature saline was injected rapidly by hand into the left coronary artery 3 times. The resting mean transit time was recorded each time and then averaged. Intracoronary papaverine (20 mg) was given, and 3 more injections of 3 mL of room temperature saline were quickly performed. The hyperemic mean transit time was recorded each time and then averaged. CFRthermo was defined as the average resting mean transit time divided by the average hyperemic mean transit time.1
After an acceptable flow signal was obtained from the Doppler wire, which at times necessitated pulling the Doppler velocity wire more proximally, the resting average peak velocity was recorded. During peak hyperemia, the average peak velocity was again recorded, ensuring that the wire position had not moved. CFRDoppler was calculated by dividing the hyperemic by the resting average peak velocities.
Absolute flow (mL/min) at rest and during peak hyperemia was recorded from the external flow probe, which measures volume flow directly and independent of vessel diameter.6 CFRflow was calculated from the ratio of hyperemic to resting coronary flow recorded from the flow probe. FFR was calculated during peak hyperemia by dividing the mean distal coronary pressure, recorded from the pressure wire, by the mean proximal coronary pressure, recorded from the guide catheter.
Statistical Analysis
Continuous values are presented as mean±SD. Simple regression analysis was used to calculate the correlation between CFRthermo and CFRflow and between CFRDoppler and CFRflow. Bland-Altman analysis was performed to further determine the agreement between the measurement methods. A probability value <0.05 was considered statistically significant. Statistical calculations were performed with StatView software (SAS Institute Inc) and MedCalc software.
| Results |
|---|
|
|
|---|
CFRthermo correlated well with the reference standard, CFRflow (r=0.85, y=0.34+0.94xx, P<0.0001). CFRDoppler also correlated with CFRflow, but not as strongly (r=0.72, y=0.61+0.62xx, P<0.0001; Figures 1 and 2
). There was a similar, less strong correlation between CFRthermo and CFRDoppler (r=0.74, y=0.54+0.66xx, P<0.0001). Bland-Altman analysis demonstrated a closer agreement between CFRthermo and CFRflow than between CFRDoppler and CFRflow (Figures 1 and 2
). Although FFR is an epicardial specific index, there was still a significant correlation between FFR and both CFRthermo (r=0.46, y=0.66+0.08xx, P<0.001) and CFRflow (r=0.42, y=0.68+0.078xx, P=0.001). FFR did not correlate significantly with CFRDoppler (r=0.24, y=0.74+0.05xx, P=0.07).
|
|
| Discussion |
|---|
|
|
|---|
In particular, there was a greater degree of scatter between the CFRDoppler and CFRflow values, especially at higher levels of CFR; CFRDoppler tended to underestimate the true CFR. There may be both conceptual and technical reasons to explain this underestimation. For example, accurate measurement of CFR with the Doppler wire assumes the same (parabolic) flow profile exists at all flow rates; in fact, the flow profile may be different at high and low flow rates, and thus the peak velocity recorded by Doppler may not correlate precisely with the actual flow. In addition, early work validating CFRDoppler found that technical issues, such as vessel tortuosity, could limit the accuracy of this technique, presumably by not allowing the Doppler sensor to remain in the middle of the vessel.7 The significance of this technical issue may be greater at higher flow rates.
CFR remains a useful measurement in the cardiac catheterization laboratory because it interrogates the functional status of the entire coronary arterial system, including both the epicardial artery and the microcirculation, whereas FFR is epicardial artery specific. Determination of FFR alone can be helpful when evaluating an intermediate coronary lesion810 or the result of a percutaneous coronary intervention,11,12 or in the determination of the culprit lesion in a patient with multivessel disease13; however, measuring both FFR and CFR simultaneously is complementary, because it allows one to distinguish better between epicardial and microvascular abnormalities.14 This ability to measure easily the 2 indices would be particularly applicable to patients with abnormalities in both areas of the coronary arterial system, such as diabetics, hypertensives, those with a previous myocardial infarction, and cardiac transplant recipients.15 To date, however, this has been hampered by the requirement for 2 coronary wires, a pressure wire and a Doppler velocity wire.
Study Limitations
This study is limited by the fact that it was performed in an animal model. However, an invasive
gold standard
for CFR is not readily available in patients. CFRflow served as the reference standard in this study and was measured in the proximal portion of the LAD, whereas CFRthermo by definition was measured distally, and CFRDoppler most commonly was measured distally. The position of measurement could have affected the results, although one would expect CFR to be uniform along the length of the LAD. Despite the findings in the present study, CFRthermo is subject to the same limitations of CFR in general; in particular, CFR is affected by baseline conditions, hemodynamic perturbations, and interindividual variability.
| Conclusions |
|---|
|
|
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
V. Stangl, V. Witzel, G. Baumann, and K. Stangl Current diagnostic concepts to detect coronary artery disease in women Eur. Heart J., March 2, 2008; 29(6): 707 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Fearon, M. Shah, M. Ng, T. Brinton, A. Wilson, J. A. Tremmel, I. Schnittger, D. P. Lee, R. H. Vagelos, P. J. Fitzgerald, et al. Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction. J. Am. Coll. Cardiol., February 5, 2008; 51(5): 560 - 565. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Melikian, M. T. Kearney, M. R. Thomas, B. De Bruyne, A. M. Shah, and P. A. MacCarthy A simple thermodilution technique to assess coronary endothelium-dependent microvascular function in humans: validation and comparison with coronary flow reserve Eur. Heart J., September 2, 2007; 28(18): 2188 - 2194. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Kern, A. Lerman, J.-W. Bech, B. De Bruyne, E. Eeckhout, W. F. Fearon, S. T. Higano, M. J. Lim, M. Meuwissen, J. J. Piek, et al. Physiological Assessment of Coronary Artery Disease in the Cardiac Catheterization Laboratory: A Scientific Statement From the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology Circulation, September 19, 2006; 114(12): 1321 - 1341. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K.C. Ng, A. C. Yeung, and W. F. Fearon Invasive Assessment of the Coronary Microcirculation: Superior Reproducibility and Less Hemodynamic Dependence of Index of Microcirculatory Resistance Compared With Coronary Flow Reserve Circulation, May 2, 2006; 113(17): 2054 - 2061. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Roy, R. K. Banerjee, L. H. Back, M. R. Back, S. Khoury, and R. W. Millard Delineating the guide-wire flow obstruction effect in assessment of fractional flow reserve and coronary flow reserve measurements Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H392 - H397. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. MacCarthy, A. Berger, G. Manoharan, J. Bartunek, E. Barbato, W. Wijns, G. R. Heyndrickx, N. H.J. Pijls, and B. De Bruyne Pressure-derived measurement of coronary flow reserve J. Am. Coll. Cardiol., January 18, 2005; 45(2): 216 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Fearon, W. Aarnoudse, N. H.J. Pijls, B. De Bruyne, L. B. Balsam, D. T. Cooke, R. C. Robbins, P. J. Fitzgerald, A. C. Yeung, and P. G. Yock Microvascular Resistance Is Not Influenced by Epicardial Coronary Artery Stenosis Severity: Experimental Validation Circulation, May 18, 2004; 109(19): 2269 - 2272. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |